Mar 28, 2017 - Health

FDA approves new eczema drug, list price set at $37k

Rodrigo Cid, Sanofi / AP

The FDA approved Regeneron Pharmaceuticals Inc. and Sanofi SA's new eczema drug Dupixent for sale today with the companies setting the list price at $37,000 annually, per the WSJ.

The companies made a point to negotiate with pharmacy-benefit managers and non-profit officials to set an acceptable price to ensure that patients can receive the drug with the fewest restrictions possible. Even still, CVS Health Corp. told the WSJ that the drug "will be expensive" for patients.

Still, the pricing is a genuine compromise that shows Regeneron and Sanofi put some thought into their decision given the political dynamics and negative headlines that have recently plagued high drug pricing.

Go deeper

Axios
Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 12:30 p.m. ET: 32,626,165 — Total deaths: 990,134 — Total recoveries: 22,523,822 — Map.
  2. U.S.: Total confirmed cases as of 12:30 p.m. ET: 7,040,313 — Total deaths: 203,918 — Total recoveries: 2,727,335 — Total tests: 99,488,275 — Map.
  3. States: U.S. reports over 55,000 new coronavirus cases — "We’re not closing anything going forward": Florida fully lifts COVID restaurant restrictions.
  4. Health: Young people accounted for 20% of cases this summer — The long-term pain of the mental health pandemic — Fewer than 10% of Americans have coronavirus antibodies.
  5. Business: Millions start new businesses in time of coronavirus.
  6. Education: Summer college enrollment offers a glimpse of COVID-19's effect.
Go deeper (<1 min. read)Arrow
Jim VandeHei, Mike Allen
2 hours ago - Politics & Policy

America on edge as unrest rises

Louisville on Wednesday. Photo: Jon Cherry/Getty Images

Rarely have national security officials, governors, tech CEOs and activists agreed as broadly and fervently as they do about the possibility of historic civil unrest in America.

Why it matters: The ingredients are clear for all to see — epic fights over racism, abortion, elections, the virus and policing, stirred by misinformation and calls to action on social media, at a time of stress over the pandemic.

Go deeper (1 min. read)Arrow
Bryan Walsh, author of Future
3 hours ago - Health

The long-term pain of the mental health pandemic

Illustration: Sarah Grillo/Axios

A less visible but still massive trauma caused by the coronavirus is becoming clear: our mental health is suffering with potentially long-lasting consequences.

Why it matters: Mental health disorders that range from schizophrenia to depression and anxiety exert a severe cost on personal health and the economy. Addressing that challenge may require out-of-the-box solutions.

Go deeper (2 min. read)Arrow